Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 80,070,968
  • Shares Outstanding, K 1,245,853
  • Annual Sales, $ 27,116 M
  • Annual Income, $ 5,665 M
  • 60-Month Beta 0.20
  • Price/Sales 2.99
  • Price/Cash Flow 7.27
  • Price/Book 4.64
Trade GILD with:

Options Overview Details

View History
  • Implied Volatility 23.11% ( -0.33%)
  • Historical Volatility 20.08%
  • IV Percentile 65%
  • IV Rank 49.99%
  • IV High 29.79% on 10/27/23
  • IV Low 16.44% on 12/05/23
  • Put/Call Vol Ratio 0.42
  • Today's Volume 6,693
  • Volume Avg (30-Day) 13,704
  • Put/Call OI Ratio 0.79
  • Today's Open Interest 283,568
  • Open Int (30-Day) 279,766

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 1.58
  • Number of Estimates 11
  • High Estimate 1.69
  • Low Estimate 1.42
  • Prior Year 1.34
  • Growth Rate Est. (year over year) +17.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.07 +1.71%
on 05/31/24
68.04 -7.21%
on 05/20/24
-4.59 (-6.78%)
since 05/17/24
3-Month
62.07 +1.71%
on 05/31/24
74.28 -15.01%
on 03/21/24
-10.13 (-13.83%)
since 03/18/24
52-Week
62.07 +1.71%
on 05/31/24
87.86 -28.15%
on 01/19/24
-15.73 (-19.95%)
since 06/16/23

Most Recent Stories

More News
Is Gilead Sciences Stock Underperforming the Nasdaq?

Gilead Sciences has recently underperformed the broader Nasdaq Composite, but analysts are reasonably bullish about the stock’s outlook.

GILD : 62.96 (-2.04%)
$NASX : 17,842.29 (-0.08%)
AMGN : 304.04 (+0.25%)
3 Stocks With Mouthwatering Dividends You Can Buy Right Now

These stocks offer great dividends and more.

GILD : 62.96 (-2.04%)
OGN : 20.33 (-0.10%)
PFE : 27.23 (+0.93%)
3 Dividend Growth Stocks to Buy and Hold

These three dividend-paying growth stocks are worth a look at current levels as the odds rise for Fed rate cuts.

NKE : 94.86 (-0.15%)
GILD : 62.96 (-2.04%)
GBX : 50.40 (+0.36%)
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?

If you're looking for big income from blue-chip companies, these picks are for you.

COMP : 3.62 (+1.40%)
WBA : 15.43 (+1.85%)
KHC : 32.64 (-0.85%)
GILD : 62.96 (-2.04%)
3 Cathie Wood Biotech Stocks That Analysts Expect to Double

This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference...

ARKK : 43.86 (-0.61%)
NTLA : 25.01 (-0.64%)
PRME : 6.41 (+0.94%)
BEAM : 23.39 (-2.66%)
XBI : 89.95 (-0.71%)
WFC : 58.72 (+0.82%)
VKTX : 51.31 (-1.36%)
CRSP : 61.54 (-0.39%)
ABBV : 171.54 (+1.10%)
AMGN : 304.04 (+0.25%)
BMY : 40.12 (-2.07%)
GILD : 62.96 (-2.04%)
2 Beaten-Down Dividend Stocks to Buy and Hold For 10 Years

These companies have grown their dividends despite some troubles.

CVS : 61.27 (+0.29%)
GILD : 62.96 (-2.04%)
Gilead Sciences Stock Outlook: Is Wall Street Bullish or Bearish?

Gilead Sciences has underperformed the broader market YTD, but Wall Street analysts are still cautiously optimistic about the stock’s prospects.

GILD : 62.96 (-2.04%)
$SPX : 5,480.00 (+0.12%)
XLV : 145.81 (+0.05%)
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript

GILD earnings call for the period ending March 31, 2024.

GILD : 62.96 (-2.04%)
Gilead: Q1 Earnings Snapshot

Gilead: Q1 Earnings Snapshot

GILD : 62.96 (-2.04%)
Stocks Plunge Before the Open as Meta’s Revenue Forecast Disappoints, U.S. GDP Data and Earnings in Focus

June S&P 500 E-Mini futures (ESM24) are down -0.53%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.87% this morning as a disappointing revenue outlook for the current quarter from Meta weighed...

ESM24 : 5,484.00 (+0.10%)
NQM24 : 19,904.00 (-0.09%)
META : 497.80 (-1.74%)
TSLA : 184.23 (-1.71%)
HAS : 60.74 (-1.36%)
TXN : 195.88 (+0.50%)
ODFL : 172.91 (-0.58%)
MSFT : 447.01 (-0.30%)
GOOGL : 174.87 (-1.34%)
MRK : 127.83 (+0.26%)
GILD : 62.96 (-2.04%)
CAT : 325.09 (+0.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya,...

See More

Key Turning Points

3rd Resistance Point 65.75
2nd Resistance Point 65.35
1st Resistance Point 64.81
Last Price 62.96
1st Support Level 63.87
2nd Support Level 63.46
3rd Support Level 62.92

See More

52-Week High 87.86
Fibonacci 61.8% 78.01
Fibonacci 50% 74.97
Fibonacci 38.2% 71.92
Last Price 62.96
52-Week Low 62.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar